Treatment of toxoplasmosis: Current options and future perspectives

dc.creator	Konstantinović, Neda M.
dc.creator	Guegan, Helene
dc.creator	Štajner, Tijana
dc.creator	Belaz, S.
dc.creator	Robert-Gangneux, Florence
dc.date.accessioned	2021-04-20T13:03:58Z
dc.date.available	2021-04-20T13:03:58Z
dc.date.issued	2019
dc.identifier.issn	2405-6766
dc.identifier.uri	http://rimi.imi.bg.ac.rs/handle/123456789/959
dc.description.abstract	Toxoplasmosis is a worldwide parasitic disease infecting about one third of humans, with possible severe outcomes in neonates and immunocompromised patients. Despite continuous and successful efforts to improve diagnosis, therapeutic schemes have barely evolved since many years. This article aims at reviewing the main clinical trials and current treatment practices, and at addressing future perspectives in the light of ongoing researches.	en
dc.rights	openAccess
dc.rights.uri	https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.source	Food & Waterborne Parasitology
dc.title	Treatment of toxoplasmosis: Current options and future perspectives	en
dc.type	article
dc.rights.license	BY-NC-ND
dc.citation.other	15: -
dc.citation.volume	15
dc.identifier.doi	10.1016/j.fawpar.2019.e00036
dc.identifier.fulltext	http://rimi.imi.bg.ac.rs/bitstream/id/756/956.pdf
dc.identifier.scopus	2-s2.0-85064631167
dc.type.version	publishedVersion